Category: Emerging Infectious Diseases
Ambulance officer succumbs to Ebola – MoH
(Monitor) An ambulance officer is the latest victim of Ebola Virus Disease that has so far infected 131 people and killed 49 in Uganda, according to government. Alex Ndizihiwe was announced dead on Friday by Ministry of Health spokesperson, Mr Emmanuel Ainebyoona.
Nov 7, 2022
CDC Warns on Early Wave of Respiratory Illnesses
(MedPageToday) The CDC is warning of elevated levels of non-COVID respiratory illnesses in recent weeks — including rising cases of influenza, respiratory syncytial virus (RSV), and rhinovirus. The surge stands in contrast to the lower activity of these viruses seen during the past couple of pandemic years, as a result of the various mitigation measures […]
Nov 4, 2022
Pulmonary Dysfunction after Pediatric COVID-19
(Radiology) Long COVID occurs in lower frequency in children and adolescents than in adults. Morphologic and free-breathing phase-resolved functional low-field MRI may identify persistent pulmonary manifestations after SARS-CoV-2 infection.
Nov 4, 2022
EU Approves First Monoclonal Antibody To Prevent RSV In All Children As U.S. Cases Surge
(Forbes) The European Commission on Friday approved the first monoclonal antibody to prevent respiratory syncytial virus (RSV) among all infants and newborns, amid a rise of cases of the highly contagious virus, which can pose a danger to infants and older adults. The European Commission approved Beyfortus, an injection manufactured by AstraZeneca and Sanofi to […]
Nov 4, 2022
RSV Is Surging: What We Know about This Common and Surprisingly Dangerous Virus
(Scientific American) As flu season picks up and experts weigh concerns about another possible COVID surge, children’s hospitals are already filling with patients with another viral threat: respiratory syncytial virus, or RSV. Even though many people haven’t heard of RSV, pretty much everyone has had it, probably multiple times, says Anthony Flores, chief of pediatric infectious […]
Nov 4, 2022
(Pfizer) today announced the advancement of an mRNA-based combination vaccine candidate for influenza and COVID-19 to a Phase 1 trial with the aim to address two severe respiratory diseases with one vaccine. The first participant has been dosed in a Phase 1 trial evaluating the safety, tolerability, and immunogenicity of a nucleoside-modified RNA (modRNA)-based combination […]
Nov 4, 2022
(CDC) We investigated a cluster of SARS-CoV-2 infections in a quarantine hotel in Taiwan in December 2021. The cluster involved 3 case patients who lived in nonadjacent rooms on different floors. They had no direct contact during their stay. By direct exploration of the space above the room ceilings, we found residual tunnels, wall defects, […]
Nov 4, 2022
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
(ABC News) American pharmaceutical company Pfizer and its German partner BioNTech announced Friday that a booster dose of their bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of their original vaccine.According to a joint press release, updated data from a Phase 2-3 clinical trial shows […]
Nov 4, 2022
11/4/2022 Health Care Worker Ebola Fatality at Mubende Regional Referral Hospital 11/4/2022 WHO Africa Ebola Report #42 11/4/2022 Uganda says Ebola outbreak death toll rises to 48 (Reuters) The death toll from an Ebola outbreak in Uganda has risen to 48, with 131 confirmed cases, a health official involved in managing the outbreak said on […]
Nov 4, 2022
A Reporter in Search of Long Covid’s Impact
(Bloomberg Prognosis/Jason Gale) While the evidence is still emerging, what’s clear already is that the social and economic impacts are profound. Harvard economist David Cutler puts the cost of long Covid at $3.7 trillion in the US alone. And the condition could impair more than 140 million people worldwide.
Nov 3, 2022